Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 13,916 | 13,722 | 11,470 | 12,242 | 14,087 |
| Operating Income | -13,916 | -13,722 | -11,470 | -12,242 | -14,087 |
| Interest Expense | 0 | 0 | 0 | 1 | 1 |
| Other Income | 2,099 | 1,400 | 1,119 | 845 | 815 |
| Pre-tax Income | -11,817 | -12,322 | -10,351 | -11,398 | -13,273 |
| Income Tax | -15 | -21 | -11 | 17 | -31 |
| Net Income Continuous | -11,802 | -12,301 | -10,340 | -11,415 | -13,242 |
| Net Income | $-11,802 | $-12,301 | $-10,340 | $-11,415 | $-13,242 |
| EPS Basic Total Ops | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 |
| EPS Basic Continuous Ops | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 |
| EPS Diluted Total Ops | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 |
| EPS Diluted Continuous Ops | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.09 | -0.09 | -0.11 | -0.13 |
| EBITDA(a) | $-13,878 | $-13,684 | $-11,433 | $-12,204 | $-14,051 |